Population Pharmacokinetics and Exposure-Response with Teclistamab in Patients With Relapsed/Refractory Multiple Myeloma: Results From MajesTEC-1.
Xin Miao,Liviawati S Wu,Shun Xin Wang Lin,Yan Xu,Yang Chen,Yuki Iwaki,Rachel Kobos,Tara Stephenson,Kristy Kemmerer,Clarissa M Uhlar,Arnob Banerjee,Jenna D Goldberg,Danielle Trancucci,Amit Apte,Raluca Verona,Lixia Pei,Rachit Desai,Kathleen Hickey,Yaming Su,Daniele Ouellet,Mahesh N Samtani,Yue Guo,Alfred L Garfall,Amrita Krishnan,Saad Z Usmani,Honghui Zhou,Suzette Girgis Targeted oncology（2023）
摘要
NCT03145181 (phase I, 09 May 2017); NCT04557098 (phase II, 21 September 2020).
更多查看译文
AI 理解论文
溯源树
样例
